SS
Sushil Satwani
About Sushil Satwani
Sushil Satwani has 20 years in corporate governance. Holds Partner and Designated Partner roles. Currently with 3 companies, including Meraki Bvm Llp and Rareacre Free Hold Llp. Formerly with 2 companies, such as Symbiotec Pharmalab Limited and Indore Forex Services Private Limited. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Meraki Bvm Llp
AAV-6224
|
Partner | 29 Jan 2021 | 2021 | Active |
Rareacre Free Hold Llp
AAU-9788
|
Designated Partner | 29 Dec 2020 | 2020 | Active |
Tdv Commercials Llp
ACA-1775
|
Designated Partner | 11 Mar 2023 | 2023 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Symbiotec Pharmalab Limited
U24232MP2002PLC015293
|
Director | 30 Oct 2005 | 2002 | Active |
Indore Forex Services Private Limited
U67110MP2019PTC047669
|
Director | 31 Jan 2019 | 2019 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sushil Satwani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sushil Satwani
Sushil Satwani has 20 years in corporate governance. Holds Partner and Designated Partner roles. Currently with 3 companies, including Meraki Bvm Llp and Rareacre Free Hold Llp. Formerly with 2 companies, such as Symbiotec Pharmalab Limited and Indore Forex Services Private Limited. Engaged in General Business. Contributes to corporate operations.
Sushil Satwani is associated with 3 companies as Partner and Designated Partner.
Sushil Satwani has expertise in General Business.
Sushil Satwani has 20 years in corporate governance.